Pulmonary artery perfusion with anti-tumor necrosis factor alpha antibody reduces cardiopulmonary bypass-induced inflammatory lung injury in a rabbit model

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Yu, Yang ^a   Gao, Mingxin ^a   Li, Haitao ^a   Zhang, Fan ^a   Gu, Chengxiong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANTIBODIES; CARDIOPULMONARY BYPASS; FEMALE; MALE; PERFUSION; POSTOPERATIVE COMPLICATIONS; PULMONARY ARTERY; RABBITS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84893620670     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083236     Document Type: Article

References (22)

1. Rong J, Ye S, Liang MY, Chen GX, Liu H, et al. (2013) Receptor for advanced glycation end products involved in lung ischemia reperfusion injury in cardiopulmonary bypass attenuated by controlled oxygen reperfusion in a canine model. ASAIO J 59: 302-308.
2. Luan ZG, Zhang J, Yin XH, Ma XC, Guo RX (2013) Ethyl pyruvate significantly inhibits tumour necrosis factor-a, interleukin-1b and high mobility group box 1 releasing and attenuates sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury. Clin Exp Immunol 172: 417-426.
3. Klass O, Fischer UM, Antonyan A, Bosse M, Fischer JH, et al. (2007) Pneumocyte apoptosis induction during cardiopulmonary bypass: effective prevention by radical scavenging using N-acetylcysteine. J Invest Surg 20: 349-356.
4. Qi D, Gao MX, Yu Y (2013) Intratracheal antitumor necrosis factor-a antibody attenuates lung tissue damage following cardiopulmonary bypass. Artif Organs 37: 142-149.
5. Yu Y, Qi D, XIA Q (2004) The protective effect of anti-tumor necrosis factoralpha antibody on lung injury after cardiopulmonary bypass. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 11: 35-38.
6. Yu Y, Ye M, Xia Q (2003) Establishment of a rabbit model of cardiopulmonary bypass. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 10:151-152.
7. Sewing AC, Kantores C, Ivanovska J, Lee AH, Masood A, et al. (2012) Therapeutic hypercapnia prevents bleomycin-induced pulmonary hypertension in neonatal rats by limiting macrophage-derived tumor necrosis factor-α. Am J Physiol Lung Cell Mol Physiol 303: L75-87.
8. Goebel U, Siepe M, Mecklenburg A, Doenst T, Beyersdorf F, et al. (2008) Reduced pulmonary inflammatory response during cardiopulmonary bypass: effects of combined pulmonary perfusion and carbon monoxide inhalation. Eur J Cardiothorac Surg 34: 1165-1172.
9. Veltkamp C, Anstaett M, Wahl K, Möller S, Gangl S, et al. (2011) Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNF-α treatment. Gut 60: 1345-1353.
10. Li T, Luo N, Du L, Liu J, Gong L, et al. (2012) Early and marked up-regulation of TNF-α in acute respiratory distress syndrome after cardiopulmonary bypass. Front Med 6: 296-301.
11. Kearney CJ, Sheridan C, Cullen SP, Tynan GA, Logue SE, et al. (2013) Inhibitor of Apoptosis Proteins (IAPs) and Their Antagonists Regulate Spontaneous and Tumor Necrosis Factor (TNF)-induced Proinflammatory Cytokine and Chemokine Production. J Biol Chem 288: 4878-4890.
12. Lisby S, Faurschou A, Gniadecki R (2007) The autocrine TNFalpha signalling loop in keratinocytes requires atypical PKC species and NF-kappaB activation but is independent of cholesterol-enriched membrane microdomains. Biochem Pharmacol 73: 526-533. (Pubitemid 46038860)
13. Szlosarek PW, Grimshaw MJ, Kulbe H, Wilson JL, Wilbanks GD, et al. (2006) Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium. Mol Cancer Ther 5: 382-390.
14. Wang C, Li D, Qian Y, Wang J, Jing H (2012) Increased matrix metalloproteinase-9 activity and mRNA expression in lung injury following cardiopulmonary bypass. Lab Invest 92: 910-916.
15. Binns OA, DeLima NF, Buchanan SA, Cope JT, King RC, et al. (1996) Both blood and crystalloid-based extracellular solutions are superior to intracellular solutions for lung preservation. J Thorac Cardiovasc Surg 112: 1515-1521. (Pubitemid 26425724)
16. Kakishita T, Oto T, Hori S, Miyoshi K, Otani S, et al. (2010) Suppression of Inflammatory Cytokines During Ex Vivo Lung Perfusion With an Adsorbent Membrane. Ann Thorac Surg 89: 1773-1779.
17. Sugimoto R, Tanaka Y, Noda K, Kawamura T, Toyoda Y, et al. (2012) Preservation solution supplemented with biliverdin prevents lung cold ischaemia/reperfusion injury. Eur J Cardiothorac Surg 42: 1035-1041.
18. Santini F, Onorati F, Telesca M, Menon T, Mazzi P, et al. (2012) Selective pulmonary pulsatile perfusion with oxygenated blood during cardiopulmonary bypass attenuates lung tissue inflammation but does not affect circulating cytokine levels. Eur J Cardiothorac Surg 42: 942-950.
19. Radovits T, Beller CJ, Groves JT, Merkely B, Karck M, et al. (2012) Effects of FP15, a peroxynitrite decomposition catalyst on cardiac and pulmonary function after cardiopulmonary bypass. Eur J Cardiothorac Surg 41: 391-396.
20. Yan XC, Zhou T, Yanyan Tao, Wang QL, Liu P, et al. (2010) Salvianolic acid B attenuates hepatocyte apoptosis by regulating mediators in death receptor and mitochondrial pathways. Exp Biol Med 235: 623-632.
21. Kroon A, Riccio VD, Tseu I, Huang Z, Wang J, et al. (2012) 233 Mechanical Ventilation-Induced Apoptosis in Newborn Rat Lung is Mediated Via Fasl/Fas Pathway. Arch Dis Child 97: A67-A68.
22. 2+ in human airway smooth muscle cells. Am J Physiol Cell Physiol 303: C244-C256.